Renal Cancer - Results from #40

Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial. December 9, 2024

Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma? December 6, 2024

Retrograde aortic dissection encountered amidst nephrectomy for renal cell carcinoma with IVC thrombus - a case report. December 6, 2024

Predictive nomogram for ischemic stroke risk in clear cell renal cell carcinoma patients. December 5, 2024

Normothermic cardiopulmonary bypass and beating heart surgery for renal cell cancer with tumor thrombus extension into inferior vena cava and right atrium: a less invasive strategy. December 5, 2024

Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials. December 4, 2024

Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer Specific Mortality and All-Cause Mortality. December 4, 2024

Combining Transarterial Embolization and Percutaneous Cryoablation for Early-Stage Renal Cell Carcinoma: Embolization Materials and Impacts of Tumor Size. December 3, 2024

Renal cell carcinoma with inferior vena cava thrombus: Survival and prognostic factors in surgically treated patients. December 3, 2024

STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma. December 2, 2024

Late Survival and Long-Term Follow-Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus. December 2, 2024

Comparison of outcomes between single-port and multi-port robotic radical nephrectomy. November 29, 2024

Adverse events after nivolumab and ipilimumab combined immunotherapy in advanced renal cell carcinoma: a multicentre experience in Poland. November 29, 2024

Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma. November 28, 2024

Calcium Channel Blocker Versus Renin-Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score-Matched Cohort Study. November 28, 2024

Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. November 27, 2024

Papillary renal cell carcinoma revisited: impact of the World Health Organization 2022 classification on prognostication. November 27, 2024

French AFU Cancer Committee Guidelines - Update 2024-2026: Management of kidney cancer. November 26, 2024

Synchronized autologous T-cell immunotherapy with hyperthermia to previously heavy treated advanced renal cell carcinoma. November 26, 2024

Association between the systemic inflammation response index and kidney stones in US adults: a cross-sectional study based on NHANES 2007-2018. November 26, 2024

Page 3 of 457